Source: International Congress 2014 – ILDs 1
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Wujak, Y. Chen, K. T. Preissner, M. Wygrecka (Giessen, Germany). Low density lipoprotein receptor-related protein 1 is a novel activator of beta1 Integrin-dependent fibroblast adhesion, spreading and migration. Eur Respir J 2014; 44: Suppl. 58, 749

Member's Comments

No comment yet.

Related content which might interest you: Secreted frizzled-related protein 1 (Sfrp1) as key mediator of growth-factor induced invasion Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Expression of macrophage migration inhibitory factor in patients with idiopathic pulmonary fibrosis Source: International Congress 2015 – Interstitial lung diseases II Year: 2015 Elevated protein arginine methyltransferase 1 expression contributes to the pathogenesis of pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation Year: 2013 Fibroblast growth factor 9 (FGF9) modulates the phenotype of control and fibrotic human lung fibroblasts in vitro Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Neutrophil vascular endothelial growth factor (VEGF) as a driving force for angiogenesis in bronchiectasis? Source: International Congress 2016 – New findings in mucosal immunology Year: 2016 Romidepsin (FK228) target focal adhesion kinase (FAK) expression in lung fibrosis Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 Mast cells and fibroblasts work in concert to aggravate pulmonary fibrosis: Role of transmembrane SCF and PAR-2/PKCalpha/Raf-1/p44/42 signaling pathway Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities Year: 2013 Induced pluripotent stem cells conditioned media (iPS-cm) modulates macrophage phenotype in the fibrotic lung Source: International Congress 2014 – Lung cell biology in injury and repair Year: 2014 Targetingpyruvate kinase M2 isoform inhibits proliferation of human lung fibroblasts Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Toll like receptor 4 activation upregulates miR-181b attenuating pulmonary fibrosis via targeting TGFBR1 Source: International Congress 2015 – Latest news on miRNAs in pulmonary research Year: 2015 Altered protein homeostasis in pulmonary fibrosis indicates a role for proteasomal activator 200 Source: International Congress 2014 – New and old players in fibrotic lung disease Year: 2014 Fibroblast growth factor 9 (FGF9) modulates mesothelial cells plasticity to decrease differentiation and migration in vitro Source: International Congress 2016 – Common mechanisms in lung development and fibrosis Year: 2016 A potential role for endothelial adhesion molecules and cytokines in chemotherapy-induced lung fibrosis Source: International Congress 2014 – Cell biology 2014 Year: 2014 Parenchymal cell populations involved in the development of fibrosis Source: International Congress 2014 – ILDs 4 Year: 2014 KCa3.1 mediates alphaSMA expression in human lung myofibroblast via the Smad2/3 and TGFbeta1 signalling pathway Source: International Congress 2014 – Cell biology 2014 Year: 2014 Role of macrophage activation in type II alveolar cells transplantation for the treatment of idiopathic pulmonary fibrosis Source: Annual Congress 2013 –Translational studies in chronic repair and remodelling in the lung Year: 2013 Focal adhesions control stretch-induced rho signaling and vascular permeability via paxillin – GEF-H1 functional complex Source: International Congress 2014 – Experimental models in acute lung injury Year: 2014 Metabolic shift during TGF- β-induced collagen synthesis Source: International Congress 2016 – IPF pathogenesis Year: 2016 Dasatinib suppresses TGFbeta-induced epithelial mesenchymal transition and inhibits pulmonary fibrosis Source: International Congress 2014 – ILDs 1 Year: 2014